BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 314 filers reported holding BLUEBIRD BIO INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73,628 | -9.4% | 24,219 | -2.0% | 0.00% | 0.0% |
Q2 2023 | $81,298 | -7.2% | 24,710 | -10.3% | 0.00% | -20.0% |
Q1 2023 | $87,638 | -54.0% | 27,559 | 0.0% | 0.01% | -54.5% |
Q4 2022 | $190,708 | +9.6% | 27,559 | 0.0% | 0.01% | +10.0% |
Q3 2022 | $174,000 | +55.4% | 27,559 | +1.8% | 0.01% | +66.7% |
Q2 2022 | $112,000 | -15.2% | 27,068 | -0.5% | 0.01% | 0.0% |
Q1 2022 | $132,000 | -51.1% | 27,198 | +0.5% | 0.01% | -53.8% |
Q4 2021 | $270,000 | -48.8% | 27,068 | -1.9% | 0.01% | -51.9% |
Q3 2021 | $527,000 | -40.4% | 27,584 | -0.2% | 0.03% | -41.3% |
Q2 2021 | $884,000 | +10.9% | 27,639 | +4.6% | 0.05% | -2.1% |
Q1 2021 | $797,000 | -29.5% | 26,418 | +1.1% | 0.05% | -32.9% |
Q4 2020 | $1,131,000 | -19.9% | 26,136 | -0.2% | 0.07% | -28.6% |
Q3 2020 | $1,412,000 | -6.2% | 26,176 | +6.2% | 0.10% | -19.7% |
Q2 2020 | $1,505,000 | +33.0% | 24,658 | +0.1% | 0.12% | +2.5% |
Q1 2020 | $1,132,000 | -47.7% | 24,630 | -0.1% | 0.12% | -48.7% |
Q4 2019 | $2,163,000 | -4.4% | 24,655 | +0.0% | 0.23% | -12.1% |
Q3 2019 | $2,263,000 | -27.8% | 24,647 | 0.0% | 0.26% | -27.7% |
Q2 2019 | $3,135,000 | -18.1% | 24,647 | +1.3% | 0.36% | -21.3% |
Q1 2019 | $3,829,000 | +58.7% | 24,335 | +0.0% | 0.46% | +33.3% |
Q4 2018 | $2,413,000 | -31.9% | 24,327 | +0.2% | 0.35% | -20.2% |
Q3 2018 | $3,545,000 | -12.0% | 24,284 | -5.4% | 0.44% | -16.0% |
Q2 2018 | $4,029,000 | -8.1% | 25,669 | +0.0% | 0.52% | -14.1% |
Q1 2018 | $4,382,000 | -30.1% | 25,666 | -27.0% | 0.60% | -20.4% |
Q4 2017 | $6,266,000 | +34.9% | 35,181 | +4.0% | 0.76% | +27.1% |
Q3 2017 | $4,644,000 | +30.7% | 33,812 | 0.0% | 0.60% | +19.2% |
Q2 2017 | $3,552,000 | -99.9% | 33,812 | -20.2% | 0.50% | +8.0% |
Q3 2016 | $2,871,906,000 | +156492.5% | 42,371 | 0.0% | 0.46% | +43.2% |
Q2 2016 | $1,834,000 | -99.9% | 42,371 | 0.0% | 0.32% | -2.1% |
Q1 2016 | $1,800,768,000 | +168986.2% | 42,371 | +155.5% | 0.33% | +59.1% |
Q4 2015 | $1,065,000 | -33.0% | 16,582 | -10.7% | 0.21% | -38.6% |
Q3 2015 | $1,589,000 | -41.0% | 18,570 | +16.1% | 0.34% | -44.9% |
Q2 2015 | $2,694,000 | +31.0% | 16,000 | -6.0% | 0.62% | +32.3% |
Q1 2015 | $2,056,000 | +12.1% | 17,020 | -14.9% | 0.46% | +10.7% |
Q4 2014 | $1,834,000 | +42.0% | 20,000 | -44.4% | 0.42% | +44.8% |
Q3 2014 | $1,292,000 | – | 36,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
Summit X, LLC | 103,424 | $651,000 | 0.19% |